Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice

@article{Meng2015UseOA,
  title={Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice},
  author={Huan Meng and Meiying Wang and Huiyu Liu and X. Liu and A. Situ and Bobby Wu and Zhaoxia Ji and C. Chang and A. Nel},
  journal={ACS Nano},
  year={2015},
  volume={9},
  pages={3540 - 3557}
}
Recently, a commercial albumin-bound paclitaxel (PTX) nanocarrier (Abraxane) was approved as the first new drug for pancreatic ductal adenocarcinoma in almost a decade. PTX improves the pharmaceutical efficacy of the first-line pancreatic cancer drug, gemcitabine (GEM), through suppression of the tumor stroma and inhibiting the expression of the GEM-inactivating enzyme, cytidine deaminase (CDA). We asked, therefore, whether it was possible to develop a mesoporous silica nanoparticle (MSNP… Expand
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 65 REFERENCES
Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.
Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.
Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice.
Mesoporous silica nanoparticles: A multifunctional nano therapeutic system.
  • W. X. Mai, Huan Meng
  • Materials Science, Medicine
  • Integrative biology : quantitative biosciences from nano to macro
  • 2013
Combinatorial drug conjugation enables nanoparticle dual-drug delivery.
...
1
2
3
4
5
...